Recent advances in genetics highlight neuroinflammation as a major causal factor in AD pathogenesis with the identification of multiple immune-related AD risk genes such as CD33, TREM2, and major histocompatibility complex (MHC) genes [3,4,5,6]. The gene discussed is CD33; the disease is Alzheimer disease.